1. Home
  2. BCYC vs CRNC Comparison

BCYC vs CRNC Comparison

Compare BCYC & CRNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • CRNC
  • Stock Information
  • Founded
  • BCYC 2009
  • CRNC 2020
  • Country
  • BCYC United Kingdom
  • CRNC United States
  • Employees
  • BCYC N/A
  • CRNC N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • CRNC EDP Services
  • Sector
  • BCYC Health Care
  • CRNC Technology
  • Exchange
  • BCYC Nasdaq
  • CRNC Nasdaq
  • Market Cap
  • BCYC 492.1M
  • CRNC 455.3M
  • IPO Year
  • BCYC 2019
  • CRNC N/A
  • Fundamental
  • Price
  • BCYC $7.96
  • CRNC $12.29
  • Analyst Decision
  • BCYC Buy
  • CRNC Hold
  • Analyst Count
  • BCYC 11
  • CRNC 5
  • Target Price
  • BCYC $22.91
  • CRNC $10.20
  • AVG Volume (30 Days)
  • BCYC 303.4K
  • CRNC 2.2M
  • Earning Date
  • BCYC 10-30-2025
  • CRNC 11-20-2025
  • Dividend Yield
  • BCYC N/A
  • CRNC N/A
  • EPS Growth
  • BCYC N/A
  • CRNC N/A
  • EPS
  • BCYC N/A
  • CRNC N/A
  • Revenue
  • BCYC $19,281,000.00
  • CRNC $245,947,000.00
  • Revenue This Year
  • BCYC N/A
  • CRNC N/A
  • Revenue Next Year
  • BCYC N/A
  • CRNC $4.85
  • P/E Ratio
  • BCYC N/A
  • CRNC N/A
  • Revenue Growth
  • BCYC N/A
  • CRNC N/A
  • 52 Week Low
  • BCYC $6.10
  • CRNC $2.76
  • 52 Week High
  • BCYC $28.67
  • CRNC $27.50
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 58.20
  • CRNC 56.76
  • Support Level
  • BCYC $7.40
  • CRNC $10.89
  • Resistance Level
  • BCYC $8.69
  • CRNC $13.74
  • Average True Range (ATR)
  • BCYC 0.38
  • CRNC 0.93
  • MACD
  • BCYC 0.11
  • CRNC 0.04
  • Stochastic Oscillator
  • BCYC 62.23
  • CRNC 50.19

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About CRNC Cerence Inc.

Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.

Share on Social Networks: